We all recognize what an unprecedented time this is, and as we have seen over the past weeks, things are changing rapidly. The regulatory environment has been fluid, and the requirements continue to evolve. Late last week, more changes were announced, and as a result, we have decided to briefly PAUSE our testing until the regulatory requirements are clarified and confirmed.
To be clear, we remain confident in the test we have been using. It is the same test used by Stanford University Medical Center in a large population-based study. We have properly vetted the company and have no reason to believe the tests are not valid and accurate. Every positive test we have administered has a clinical course and timeline that match perfectly with the antibody response, further strengthening our trust in this testing product. This new guidance has nothing to do with the validity of the tests themselves, but pertains to the testing protocols.
Once the regulatory bodies confirm and announce their new compliance requirements, we will immediately resume testing. We do apologize for the inconvenience and disappointment this message may bring, but ask that you understand and remain patient as we work through the situation.
If you have already scheduled an appointment, my office will contact you to see if you would like to be placed on the waiting list for when we resume testing, and we are happy to initiate a refund if you have already made payment.
As we always have, we will continue to hold high the values of evidence-based medicine and compliance throughout this process.
Many thanks for your support.